Clinical Trial Update: Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children [NA]

View source ↗

Summary

Post-approval study for the Liposorber LA-15 System in children with focal segmental glomerulosclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• LIPOSORBER LA-15 System

Snippet

Sponsor: Kaneka Medical America LLC | Conditions: Focal Segmental Glomerulosclerosis | NA | Status: RECRUITING